Pages that link to "Q34300629"
Jump to navigation
Jump to search
The following pages link to Phase 1/2 Study of Atrasentan Combined with Pegylated Liposomal Doxorubicin in Platinum-Resistant Recurrent Ovarian Cancer (Q34300629):
Displaying 7 items.
- Dinosaurs and ancient civilizations: reflections on the treatment of cancer (Q24628746) (← links)
- 2017 update on the relationship between diabetes and colorectal cancer: epidemiology, potential molecular mechanisms and therapeutic implications (Q30239808) (← links)
- Cilostazol prevents endothelin-induced smooth muscle constriction and proliferation (Q34408166) (← links)
- Endothelin-1/endothelin A receptor-mediated biased signaling is a new player in modulating human ovarian cancer cell tumorigenesis. (Q34624192) (← links)
- The interconnectedness of cancer cell signaling (Q35669733) (← links)
- Endothelin receptor-A is required for the recruitment of antitumor T cells and modulates chemotherapy induction of cancer stem cells (Q36608738) (← links)
- Overcoming intratumor heterogeneity of polygenic cancer drug resistance with improved biomarker integration (Q41879186) (← links)